Our Recommendations
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
- Monkeypox: Caring for the skin (2022)
- Clinical features and management of human monkeypox: a retrospective observational study in the UK (2022)
- Hinweise zur Therapie von Affenpocken (2022)
New Publications
- Clinical management and infection prevention and control for mpox: living guideline, May 2025 (2025)
- Infection prevention and control and water sanitation and hygiene in health facilities during mpox disease outbreaks: rapid assessment tool, user guide (2025)
- Interim guidance on strengthening community detection and response during the mpox outbreak (2025)
- Infection prevention and control and water, sanitation and hygiene measures for home care and isolation for mpox in resource-limited settings: interim operational guide (2025)
- Revised National Guidelines on Mpox (2024)
Filter
54
Featured
Recommendations
11
New Publications
2
Language
Document type
Guidelines
22
Resource Platforms
5
Online Courses
5
Fact sheets
5
Studies & Reports
4
Situation Updates
3
Infographics
3
Strategic & Response Plan
3
Training Material
2
Manuals
1
No document type
1
Countries / Regions
Africa
5
Congo, Democratic Republic of
4
Germany
3
Nigeria
2
Mozambique
1
Global
1
Brazil
1
Angola
1
Pakistan
1
Authors & Publishers
Publication Years
Toolboxes
Rapid Response
53
This interim operational guide outlines infection prevention, control, and water, sanitation, and hygiene measures for home care and isolation of mpox in resource-limited settings. It focuses on practical strategies to manage and prevent the spread of the virus when persons with mpox are isolated at...
The rapid assessment tool (RAT) is meant to assess health facilities within mpox-affected areas that have at least one inpatient bed. Depending on time and resources available, certain facilities may be prioritized during an mpox outbreak. The RAT evaluates 16 infection prevention and control (IPC) ...
Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus (MPXV).1
It causes a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy or feeling sick. In most cases, the symptoms of mpox go away within a few weeks with supportive care...
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
Infographic
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...
interim guidance, 25 November 2024
Bas Uele, Equateur, Haut Uele, Ituri, Kasai, Kasai Central, Kasai Oriental, Kinshasa, Kongo Central, Kwango, Kwilu, Lomami, Lualaba,
Maindombe, Maniema, Mongala, Nord-Ubangi, Nord-Kivu, Sankuru, Sud-Kivu, Sud-Ubangi, Tshopo et Tshuapa
Ressource Platform
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Flyer German
Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV)
recommended
Orientations provisoires
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
mise à jour de la situation
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
Fiche d'information
Resource Platform
